AI assistant
CSL Ltd. — Board/Management Information 2020
Jul 15, 2020
17854_rns_2020-07-15_70f4e7e7-e70f-4fc9-a931-9bdab7821d19.pdf
Board/Management Information
Open in viewerOpens in your device viewer
For immediate release
16 July 2020
==> picture [205 x 32] intentionally omitted <==
==> picture [58 x 30] intentionally omitted <==
==> picture [262 x 27] intentionally omitted <==
CSL Appoints New Non-Executive-Director
CSL Limited (ASX:CSL; USOTC:CSLLY) is pleased to announce the appointment of Mr Pascal Soriot as an independent Non-Executive Director, to be effective from 19 August 2020.
CSL’s Chairman, Dr Brian McNamee AO said “Pascal is a highly experienced international business leader who brings to CSL’s Board a lifelong passion for science and medicine and international pharmaceutical industry insight. His deep experience in both established and emerging markets complements CSL’s global footprint and the values he has displayed in leading AstraZeneca will support CSL’s values and purpose to deliver for patients.”
Mr Soriot has served as the Chief Executive Officer of AstraZeneca, a global biopharmaceutical company since 2012 where he has led a strong pipeline of new products and delivered high growth in total shareholder returns.
From 2010-2012, he served as Chief Operating Officer of Roche’s pharmaceuticals division. Prior to that Mr Soriot was Chief Executive Officer of Genentech, a biologics business, where he led its successful integration with Roche.
Mr Soriot has worked in a variety of senior pharmaceutical management roles in France, Switzerland, Japan, Australia and the United States.
Mr Soriot is a doctor of veterinary medicine and holds an MBA from the French Business School, HEC. He resides in the United Kingdom and holds dual French and Australian citizenship.
Approved for Release Fiona Mead Company Secretary
For further information, please contact:
Media: Investors: Jemimah Brennan Mark Dehring Head of Asia Pacific Communications Head of Investor Relations Telephone: +61 412 635 483 Telephone: +61 3 9389 3407 Email: [email protected] Email: [email protected]
==> picture [99 x 7] intentionally omitted <==